Received — Decided 6 March 2023 Part-Granted Request Reference FOI-0038-2023 Requester Type Journalist Department of Health All Corrs & related documents Btw CMO & the Chief Clinical Officer/Chief Executive Officer of the HSE re: Paxlovid & other antiviral treatments for Covid-19 since October 2022.